NEW BRUNSWICK, N.J., June 12, 2017 -- Spectrum Pharmacy Institute (SPI), a state-of-the-art compounding education and training center, announces Lou Diorio, RPh, FAPhA, as Course Presenter for "USP <800> Compliance – Improving the Safety of Compounded Preparations."
In making the announcement, Craig A. Recatto, Ph.D., President of Spectrum Pharmacy Products, said, "We are honored to have Lou Diorio present this important compliance course. Lou is a nationally recognized subject matter expert on pharmaceutical compounding and healthcare consulting. His comprehensive knowledge and industry leadership will provide course attendees with added expertise to understand the new compounding standards being implemented in 2018."
With more than thirty years of practice in clinical settings, Lou Diorio, RPh, FAPhA, is a principal of LDT Health Solutions, Inc. (LDT) a medication safety and quality management consulting company serving clients nationwide. He is a graduate of Long Island University's Schwartz College of Pharmacy and Adjunct Professor of Pharmacy Practice for the College and a preceptor. Lou is a Fellow of the American Pharmacists Association (APhA), past Chair of APhA's Academy of Practice and Management, and past Chair of APhA's Compounding Special Interest Group (SIG). Published extensively, he lectures and develops educational materials for pharmaceutical companies on technical, regulatory, and marketing topics.
The United States Pharmacopeia Convention (USP) has approved and finalized new standards and guidelines for the handling of hazardous drugs (HD) in healthcare settings. July 1, 2018 is the day of implementation for USP <800>. This new chapter of compounding standards affects all healthcare personnel who handle HD preparations and all entities that store, prepare, transport or administer HDs.
SPI's 2-day course concentrates not only on the compounding of HDs, but the receipt, storage, dispensing, administration and disposal as well. Instruction will highlight the principles of protecting personnel, patients and the environment from exposure. SPI's hands-on simulation training focuses on the critical aspects in HD safety and preparation.
To register for the course or obtain more information, visit: USP <800> Compliance - Improving the Safety of Compounded Preparations.
Spectrum Pharmacy Institute Online Press Kit: http://health-event-news.vporoom.com/Spectrum
About Spectrum Pharmacy Institute (SPI)
Spectrum Pharmacy Institute is a 42,000-square foot pharmacy distribution, manufacturing, and training facility located in New Brunswick, New Jersey. SPI is committed to providing the finest academic learning experience in the industry. The Institute offers the latest comprehensive lecture-based and hands-on compounding education. Learning programs feature a cutting-edge multi-media, audio-visual classroom and laboratory experience, including ISO-Class 7 & 8 cleanrooms, fully functional teaching laboratories, current compounding equipment and supplies, and USP <800> compliant facilities. All courses are written and presented by subject matter experts, and all education programs are reviewed by faculty of the Ernest Mario School of Pharmacy at Rutgers University and jointly accredited with Spectrum Pharmacy Institute. For more information, visit spectrumpharmacyinstitute.com.
About Spectrum Pharmacy Products
Spectrum Pharmacy Products, a division of Spectrum Chemical Manufacturing Corporation, manufactures and distributes high-quality compounding chemicals, equipment and supplies. Spectrum has been serving compounders for more than 40 years with the industry's largest portfolio of USP/NF grade products and DEA Controlled Substances (Schedules I – V). Its bicoastal cGMP facilities are FDA registered and inspected, with additional certification to the ISO 9001:2008 standard. Spectrum is known for extensive laboratory testing with the highest standards and most modern instrumentation in the industry in both its New Jersey and California laboratories. For more information, visit spectrumrx.com.
Media Contact: Sandra Oak, Nsight Public Relations, 321-591-1508, [email protected]
Company Contact: Grant Gibson, Vice President, Marketing, Spectrum Chemical Mfg. Corp., 1-310-516-8000, ext. 4601, [email protected]